Skip to content
← Back to this collection

PUBLICATIONS · 29763623

Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Cell
Publication date
2018 May 14
First author
Mackay A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mackay A
      type
      Author
    2. name
      Burford A
      type
      Author
    3. name
      Molinari V
      type
      Author
    4. name
      Jones DTW
      type
      Author
    5. name
      Izquierdo E
      type
      Author
    6. name
      Brouwer-Visser J
      type
      Author
    7. name
      Giangaspero F
      type
      Author
    8. name
      Haberler C
      type
      Author
    9. name
      Pietsch T
      type
      Author
    10. name
      Jacques TS
      type
      Author
    11. name
      Figarella-Branger D
      type
      Author
    12. name
      Rodriguez D
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mackay A
      type
      Author
    2. name
      Burford A
      type
      Author
    3. name
      Molinari V
      type
      Author
    4. name
      Jones DTW
      type
      Author
    5. name
      Izquierdo E
      type
      Author
    6. name
      Brouwer-Visser J
      type
      Author
    7. name
      Giangaspero F
      type
      Author
    8. name
      Haberler C
      type
      Author
    9. name
      Pietsch T
      type
      Author
    10. name
      Jacques TS
      type
      Author
    11. name
      Figarella-Branger D
      type
      Author
    12. name
      Rodriguez D
      type
      Author
    bibliography ids
    1. nci-bib-a547010310f5cc967769fe05
    book metadata
    content sha256
    5b4900e3d613cafae8dffb3d05b3125a9ad84b0946eca0bbb7ec258562550f79
    document type
    citation
    dois
    1. 10.1016/j.ccell.2018.04.004
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29763623
    immutable id
    pubmed:29763623@5b4900e3d613cafae8dffb3d05b3125a9ad84b0946eca0bbb7ec258562550f79
    journal
    abbreviation
    Cancer Cell
    issn electronic
    1878-3686
    issn print
    1535-6108
    issue
    5
    name
    Cancer cell
    nlm unique id
    101130617
    pages
    829-842.e5
    volume
    33
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29763623
      provenance
      batch id
      c4c0356d060413f719c2
      provider
      NCBI PubMed ESummary
      record sha256
      5410338bc3c3506b121e397e1d93c0f9a46702cbab1f3c913051fd1b58ca3a5e
      response sha256
      adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
      retrieved at
      2026-09-09T23:47:33.674758+00:00
      publication date
      display
      2018 May 14
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29763623/
      title
      Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice